Literature DB >> 26456374

Higher and lower active circulating VWF levels: different facets of von Willebrand disease.

Alessandra Casonato1, Elena Pontara2, Margherita Morpurgo3, Francesca Sartorello1, Philip G De Groot4, Maria G Cattini2, Viviana Daidone2, Luigi De Marco5,6.   

Abstract

Most circulating von Willebrand factor (VWF) is normally inactive and incapable of binding platelets, but numerous disorders may modify the proportion of active VWF. We explored active VWF levels in patients with von Willebrand disease (VWD) whose VWF had a higher affinity for platelet glycoprotein (GP)Ib, but different susceptibilities to ADAMTS13 and multimer patterns (9 patients lacking large multimers, 10 with a normal pattern); 12 patients with VWF C2362F and R1819_C1948delinsS mutations, which make VWF resistant to ADAMTS13 were also studied. Type 2B patients with abnormal or normal multimers had significantly more active VWF (3·33 ± 1·6 and 3·74 ± 0·74, respectively; normal 0·99 ± 0·23). The type of VWF mutation influenced VWF activation: V1316M was associated with the highest levels in patients with abnormal multimers, and R1341W in those with normal multimers. Pregnancy induced gradually rising active VWF levels and declining platelet counts in one type 2B VWD patient without large multimers. Active VWF levels dropped significantly in patients homozygous for the C2362F mutation or heterozygous for R1819_C1948delinsS mutations (0·2 ± 0·03 and 0·23 ± 0·1, respectively), and less in cases heterozygous for the VWF C2362F mutation (0·55 ± 0·17). We demonstrate that VWF may be more or less activated, with or without any direct involvement of the A1 domain, and regardless of ADAMTS13.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  VWF mutations; a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13; active von Willebrand factor; von Willebrand disease; von Willebrand factor

Mesh:

Substances:

Year:  2015        PMID: 26456374     DOI: 10.1111/bjh.13785

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

1.  Type 2B von Willebrand disease with or without large multimers: A distinction of the two sides of the disorder is long overdue.

Authors:  Alessandra Casonato; Viviana Daidone; Eva Galletta; Antonella Bertomoro
Journal:  PLoS One       Date:  2017-06-22       Impact factor: 3.240

2.  Analytical characterization and reference interval of an enzyme-linked immunosorbent assay for active von Willebrand factor.

Authors:  Lisa N van der Vorm; Li Li; Dana Huskens; Walid Chayouâ; Hilde Kelchtermans; Philip G de Groot; Mark Roest; Jasper A Remijn; Bas de Laat
Journal:  PLoS One       Date:  2019-02-13       Impact factor: 3.240

3.  A New ELISA Using the ANANAS Technology Showing High Sensitivity to diagnose the Bovine Rhinotracheitis from Individual Sera to Pooled Milk.

Authors:  Elisabetta Casarin; Laura Lucchese; Santina Grazioli; Sonia Facchin; Nicola Realdon; Emiliana Brocchi; Margherita Morpurgo; Stefano Nardelli
Journal:  PLoS One       Date:  2016-01-13       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.